NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancerBérengère Salomé, Nina Bhardwaj, John P. Sfakianos et al.|Cancer Cell|2022Cited by 127
HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker studyVivek Naranbhai, Mary Carrington, David A. Braun et al.|The Lancet Oncology|2021Cited by 126